Cancer claims and specialty drugs drive stop-loss cost surge: QBE
The annual report, which draws on QBE’s proprietary claims data, found that neoplasms account for 36% of all stop-loss claim…
Tag: QBE
QBE lifts profits above $2 billion with best underwriting result in years
Outside catastrophe experience, QBE’s underlying claims performance was broadly stable, with an ex-cat claims ratio of 59.8% (from 59.7%). The…